Unlock instant, AI-driven research and patent intelligence for your innovation.

Medium composition for cryopreservation of cell and use thereof

A kind of technology of composition and culture medium, applied in the field of pharmaceutical composition of therapeutic cells

Active Publication Date: 2018-12-04
GREEN CROSS LAB CELL CORP
View PDF17 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, safety concerns exist in the use of compositions containing serum as direct therapeutic agents (cell therapy agents)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medium composition for cryopreservation of cell and use thereof
  • Medium composition for cryopreservation of cell and use thereof
  • Medium composition for cryopreservation of cell and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-3

[0062] Example 1-3 Preparation of medium composition for cryopreservation

[0063] To prepare a medium composition for cryopreservation, 5 ml of DMSO, 25 ml of dextran 40, 50 ml of albumin injection, and 20 ml of RPMI1640 as a cell culture medium were mixed (Example 1). In Examples 2 and 3, the same method as in Example 1 was also used but the amount shown in Table 1 below was used to prepare a freezing medium composition containing dimethyl sulfoxide (DMSO, Bioniche Pharma, USA) , Dextran 40 (Dai Han Pharm. Co., Ltd), albumin injection (Korea Green Cross), and RPMI1640 (Gibco, USA).

experiment example 1

[0069] Experimental Example 1 Evaluation of NK cells after freezing and thawing

[0070] 1.1 Freezing and thawing of NK cells

[0071] NK cells were frozen in the medium composition for freezing storage prepared in Example 1-3 and Comparative Example 1-6, and then thawed to evaluate the medium composition for freezing storage.

[0072] First, monocytes were isolated from human peripheral blood (Seoul National University Hospital, South Korea). The CliniMACS system was used to remove CD3 positive cells from the isolated monocytes and use them as seed cells. At the same time, monocytes irradiated with 2000cGy of gamma rays were used as support cells for NK cell culture. Divide seed cells and supporting cells to 0.5 x 10 6 Up to 1 x10 6 The concentration of cells / ml is cultured at SCGM medium (CellGenix, Germany), the medium is supplemented with 500IU / ml IL-2, 10μg / ml anti-CD3 antibody OKT3 and 1v / v% serum. At 37°C and 5% CO 2 Cultivate for 14-21 days under the same conditions.

[00...

experiment example 2

[0112] Experimental example 2 Evaluation of tumor cells after thawing

[0113] It was checked whether the medium composition for freezing storage prepared in Examples 1-3 and Comparative Examples 1-6 can also be used to freeze tumor cells.

[0114] First, at 37°C and 5% CO 2 The human T lymphoma cell line HuT78 (ATCC, United States) and human leukemia cell K562 (ATCC, United States) were cultured in RPMI1640 medium containing 10% fetal bovine serum and RPMI1640 medium containing 20% ​​fetal bovine serum under the conditions of ). The cultured cells were recovered and suspended in each medium. Then, place HuT78 cells and K562 cells in the vial, and place them in a volume of 1 x 10 7 Cells / ml and 4 x 10 6 The concentration of cells / ml is frozen. Cell freezing was performed by the same method as described in Experimental Example 1.1 above. Resuspend the frozen cells in each medium, and subculture the cells to obtain 1 x 10 6 Concentration of cells / ml at 37°C and 5% CO 2 Cultivate f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a medium composition for the cryopreservation of cells, which exhibits excellent cell recovery rates, cell viability rates and cell activity after thawing, and a pharmaceutical composition comprising the medium composition and therapeutic cells. Also, the medium composition of the present invention allows for readily administering the cryopreserved therapeutic cells to a subject without additional procedures such as washing, separation, etc. Therefore, the composition may be used as an excellent medium composition for cell cryopreservation or as an excellent therapeutic composition.

Description

Technical field [0001] The present invention relates to a medium composition for cell freezing storage, which exhibits excellent cell recovery rates, cell survival rates, and cell viability after thawing. The present invention also relates to a medium composition comprising the medium composition and therapeutic cells. Pharmaceutical composition. Background technique [0002] With the development of animal cell culture methods, these methods have been widely used in biological research in various fields including protein drug production. When animal cells are used to produce protein drugs, cryopreservation is mainly used as a preservation method that allows long-term maintenance of cell line characteristics. [0003] Cryopreservation can overcome the difficulties in cell culture and maintenance, and can prevent the contamination of bacteria and mycoplasma. In addition, the transformation of cell lines can be prevented, and the reproducibility of experiments and production can be ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A01N1/02A61K35/17A61K35/28C12N5/0775C12N5/0783
CPCA61K35/28A61P35/00A61P35/02A61P31/00A61P37/00A01N1/021A01N1/0221A61K39/4613A61K2239/48A61K39/4644C12N5/0646A61K2300/00A01N1/0284C12N5/0662C12N2500/34C12N2500/30A61K35/17
Inventor 黄琉炅闵普庆崔哈娜金孝珍
Owner GREEN CROSS LAB CELL CORP